Search
for
Sort by
Research 301–330 of 1000+
- Current treatment of BPH
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- The postnatal offspring of finasteride-treated male rats show altered ERα and PCNA expression in the liver
- Decision letter: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Prioritizing susceptibility genes for the prognosis of male-pattern baldness with transcriptome-wide association study
- Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I
- The Effect of EGR1 on the Proliferation of Dermal Papilla Cells
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Guidelines on the use of finasteride in androgenetic alopecia
- Minoxidil may suppress androgen receptor-related functions
- The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- A REVIEW ON PHYTOPHARMACOLOGICAL SIGNIFICANCE OF ECLIPTA ALBA
- The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Clinical use of 5α-reductase inhibitors
- New Drugs: Dutasteride
- The human keratins: biology and pathology
- Penis Endocrinology
- Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
- COVID-19 and Sex Differences
- Dermatological adverse events with taxane chemotherapy
- Drug eruptions in dermatology
- Androgen Receptor Ligands: Agonists and Antagonists
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Treatment options for alopecia: an update, looking to the future
- Hormone therapy in acne